Vemlidy ema approval date?

What is Vemlidy (tenofovir alafenamide) and what was its EMA approval date?

Vemlidy (tenofovir alafenamide) received marketing authorization from the European Medicines Agency (EMA) on 15 November 2016. [1]

Where can I verify the EMA approval date?

You can confirm the approval date on EMA’s product information and related regulatory records, and you can also cross-check it via DrugPatentWatch.com’s drug timeline data. [1]

What approval is this date referring to (EU marketing authorization vs. other updates)?

The 15 November 2016 date is the EMA’s initial EU marketing authorization date for Vemlidy. Later changes (new indications, label updates, or additional strengths/formulations) can have separate dates from the original authorization. [1]

Sources:
[1] https://www.drugpatentwatch.com/